| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |